Follow this preprint

Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments

Sarah Gleeson, Paul Martin, Tina Thomson, Amarpreet Thind, Maria Prendecki, Katrina J. Spensley, Candice L. Clarke, Candice Roufosse, Graham Pickard, David Thomas, Stephen P. McAdoo, Liz Lightstone, Peter Kelleher, Michelle Willicombe
doi: https://doi.org/10.1101/2022.05.03.22274524
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Article Information

doi 
https://doi.org/10.1101/2022.05.03.22274524
History 
  • May 3, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Sarah Gleeson*,1,2,
  2. Paul Martin2,
  3. Tina Thomson2,
  4. Amarpreet Thind1,2,
  5. Maria Prendecki1,2,
  6. Katrina J. Spensley1,2,
  7. Candice L. Clarke1,2,
  8. Candice Roufosse1,4,
  9. Graham Pickard3,
  10. David Thomas1,2,
  11. Stephen P. McAdoo1,2,
  12. Liz Lightstone1,2,
  13. Peter Kelleher3,4 and
  14. Michelle Willicombe*,1,2,†
  1. 1Centre for Inflammatory Disease, Department of Immunology and Inflammation, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0NN
  2. 2Imperial College Renal and Transplant Centre, Imperial College Healthcare NHS Trust, Hammersmith Hospital, London
  3. 3Department of Infection and Immunity Sciences Northwest London Pathology NHS Trust, Charing Cross Hospital, Fulham Palace Road W6 6RF
  4. 4Department of Infectious Diseases, Imperial College London, Chelsea &Westminster Hospital Campus, Fulham Road London SW10 9NH
  1. ↵†Corresponding author: Dr Michelle Willicombe, Centre for Inflammatory Disease Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus London, W12 0NN, E-mail: m.willicombe08{at}imperial.ac.uk

  1. ↵* These authors contributed equally to this work

Back to top
Posted May 03, 2022.
Download PDF
Print/Save Options
Download PDFFull Text & In-line FiguresXML

Supplementary Material

Data/Code
Email
Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments
Sarah Gleeson, Paul Martin, Tina Thomson, Amarpreet Thind, Maria Prendecki, Katrina J. Spensley, Candice L. Clarke, Candice Roufosse, Graham Pickard, David Thomas, Stephen P. McAdoo, Liz Lightstone, Peter Kelleher, Michelle Willicombe
medRxiv 2022.05.03.22274524; doi: https://doi.org/10.1101/2022.05.03.22274524
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area

Reviews and Context

0

Comment

0

TRIP Peer Reviews

0

Community Reviews

0

Automated Services

0

Blogs/Media

0

Author Videos

You can now receive automatic notifications when a preprint is revised, withdrawn, commented on, peer reviewed, or published in a journal. Select the events you would like to follow below and click "Submit". To see all of the preprints you are currently following, please go to the medRxiv Alerts Page.

Sign In to Follow this Preprint

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.